Elizabeth Harlos

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602)”.

Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602)

The Oncologist(2023)10.1093/oncolo/oyad140

N/A

0.229DataRank · unranked

3 citations

Jennifer Le‐Rademacher, Fabrice Smieliauskas, Kathryn J. Ruddy, Thomas J. Saphner, Heshan Liu +10 more

Patient-targeted education (ePRO-E) to increase ePRO intent within an Alliance clinical trial (A221805-SI1)

JNCI Cancer Spectrum(2024)10.1093/jncics/pkae002

N/A

0DataRank · unranked

1 citations

Youmin Cho, Shauna L. Hillman, Mary R Scott, Elizabeth Harlos, Rachel Wills +4 more